I love this idea (there would have to be careful thinking around patent resell/value restating to avoid sneaky shell company tricks). It means you don't have th

I love this idea (there would have to be careful thinking around patent resell/value restating to avoid sneaky shell company tricks). It means you don't have the problems of special-casing software (no software patents) or vice versa special-casing like big pharma stuff (only patents on drugs - which most people seem to think is a needed case for patents) - big pharma would be much happier to claim up front that drug patent is worth millions on pay tax on that. It also means that you'd get lots of press around big stated-value (and so big potential claim) patents, so people in the same industry would know which patents to avoid infringing, hopefully much reducing risk of accidental infringement.